Literature DB >> 3664932

DNA cross-linking following exposure to cis-platinum in primary and serially passaged cultured cells derived from two murine fibrosarcomas.

D Murray1, I Basic, L Milas, R E Meyn.   

Abstract

We compared the kinetics of the repair of total (ISC plus DPC) cross-links and of proteinase-resistant (ISC) cross-links in cultured cells derived from two murine fibrosarcoma tumors, FSA and NFSA, after treatment with cis-platinum (cis-DDP), using a modification of the alkaline elution technique. The two tumors had previously been characterized for their response to cis-DDP in vivo; FSA cells gradually removed cross-links from their genome, whereas the NFSA cells showed no capacity to repair these lesions. The aim of the present study was to establish whether treatment of cells from these same two tumors grown under controlled culture conditions would affect either the nature of the lesions induced by cis-DDP or the kinetics of repair of these lesions when compared with tumors treated with cis-DDP in vivo. The culture conditions represent two situations: in the first, the cells in culture approximated the proportion of tumor and normal host cells present in vivo, and in the second, the normal host cells had been eliminated by subculturing to produce cultures composed entirely of tumor cells. All cells were exposed to cis-DDP (either 10 or 20 micrograms/ml) for 1 h. The relative amounts of total cis-DDP-induced DNA crosslinks and of ISCs were then determined at various times after treatment. The results show that there was little difference in the behavior of these cultured cells compared to the in vivo response of the tumor from which they were derived. For FSA, each cell culture exhibited a capacity to repair DNA cross-links comparable to that of the tumor in vivo. For NFSA, the passaged cells again paralleled the behavior of that tumor in vivo, although in this case by showing no measurable capacity to repair cross-links. The absence of a significant repair response in the NFSA tumor therefore appears to be an intrinsic characteristic of these tumor cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3664932     DOI: 10.1007/bf00253967

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  17 in total

Review 1.  Mechanism of action of cis-dichlorodiammineplatinum(II).

Authors:  L A Zwelling; K W Kohn
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

2.  Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.

Authors:  L Milas; N Hunter; K Mason; H R Withers
Journal:  Cancer Res       Date:  1974-01       Impact factor: 12.701

Review 3.  Phenotype and functions of intratumoral macrophages.

Authors:  W H McBride
Journal:  Biochim Biophys Acta       Date:  1986-08-05

Review 4.  Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA.

Authors:  A L Pinto; S J Lippard
Journal:  Biochim Biophys Acta       Date:  1985

5.  Differential toxicity of cis- and trans-diamminedichloroplatinum(II) toward mammalian cells: lack of influence of any difference in the rates of loss of their DNA-bound adducts.

Authors:  J J Roberts; F Friedlos
Journal:  Cancer Res       Date:  1987-01-01       Impact factor: 12.701

6.  Kinetics of DNA cross-linking in normal and neoplastic mouse tissues following treatment with cis-diamminedichloroplatinum(II) in vivo.

Authors:  D Murray; W T Jenkins; R E Meyn
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

7.  Induction and repair of DNA cross-links in chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity.

Authors:  A C Plooy; M van Dijk; P H Lohman
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

8.  Increased sensitivity of UV-repair-deficient human cells to DNA bound platinum products which unlike thymine dimers are not recognized by an endonuclease extracted from Micrococcus luteus.

Authors:  H N Fraval; C J Rawlings; J J Roberts
Journal:  Mutat Res       Date:  1978-07       Impact factor: 2.433

9.  Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.

Authors:  L Milas; H Ito; N Hunter
Journal:  Cancer Res       Date:  1983-07       Impact factor: 12.701

10.  Defective DNA cross-link removal in Chinese hamster cell mutants hypersensitive to bifunctional alkylating agents.

Authors:  C A Hoy; L H Thompson; C L Mooney; E P Salazar
Journal:  Cancer Res       Date:  1985-04       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.